Cargando…
MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells
BACKGROUND: Chemotherapy is one of the most common treatment options for breast cancer (BC) patients. However, about half of the BC patients are chemotherapeutic resistant. Doxorubicin (DOX) is considered as one of the first line drugs in the treatment of BC patients whose function is negatively aff...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170947/ https://www.ncbi.nlm.nih.gov/pubmed/33858435 http://dx.doi.org/10.1186/s12935-021-01873-4 |